Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJSE:920575'
s EV-to-FCF Range Over the Past 10 Years
Min: -35 Med: -17.7 Max: -4.43
Current: -28.55
During the past 13 years, the highest EV-to-FCF of Beijing Health Guard Biotechnology was -4.43. The lowest was -35.00. And the median was -17.70.
BJSE:920575's EV-to-FCF is ranked worse than 100% of 321
companies
in the Biotechnology industry
Industry Median: 17.48
vs BJSE:920575: -28.55
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Health Guard Biotechnology (BJSE:920575) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Health Guard Biotechnology's PE Ratio (TTM) for today is calculated as:
Beijing Health Guard Biotechnology's share price for today is ¥5.59.
Beijing Health Guard Biotechnology's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.880.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Beijing Health Guard Biotechnology EV-to-FCF Related Terms
Beijing Health Guard Biotechnology EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology EV-to-FCF Chart
BJSE:920575 vs VRTX, REGN, RVMD: EV-to-FCF Comparison
For the Biotechnology subindustry, Beijing Health Guard Biotechnology's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Health Guard Biotechnology EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Beijing Health Guard Biotechnology's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Beijing Health Guard Biotechnology's EV-to-FCF falls into.
Beijing Health Guard Biotechnology's current Enterprise Value is ¥1,805.97 Mil.
Beijing Health Guard Biotechnology's Free Cash Flow for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-63.27 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Health Guard Biotechnology (BJSE:920575) has a EV-to-FCF of -28.55 as of Aug. 27, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Health Guard Biotechnology and its competitors. According to the industry distribution chart, Beijing Health Guard Biotechnology ranks #999999 out of 321 companies in the Biotechnology industry.
Is Beijing Health Guard Biotechnology's EV-to-FCF too high?
Beijing Health Guard Biotechnology's current EV-to-FCF is -28.55. Based on the distribution chart, Beijing Health Guard Biotechnology ranks #999999 out of 321 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Beijing Health Guard Biotechnology has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Beijing Health Guard Biotechnology's EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Beijing Health Guard Biotechnology ranks #999999 out of 321 companies for EV-to-FCF. This places Beijing Health Guard Biotechnology in the lower half of its industry. The industry median EV-to-FCF is 17.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 17.48, based on 321 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Beijing Health Guard Biotechnology and its competitors. For the Biotechnology industry, the median EV-to-FCF is 17.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Health Guard Biotechnology's current EV-to-FCF is -28.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Health Guard Biotechnology stock overvalued right now?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology (BJSE:920575) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.92, compared to a current price of ¥5.59 — trading 29.4% below its estimated fair value. The current EV-to-FCF is -28.55. Beijing Health Guard Biotechnology's overall GF Score™ is 47/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Beijing Health Guard Biotechnology (BJSE:920575), the current EV-to-FCF is -28.55 as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Health Guard Biotechnology (BJSE:920575) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Health Guard Biotechnology stock appears to be undervalued.
The current stock price of ¥5.59 is trading 29.4% below its estimated GF Value™ of ¥7.92.
GuruFocus considers Beijing Health Guard Biotechnology to be Modestly Undervalued.
Key valuation signals for BJSE:920575:
EV-to-FCF: -28.55
GF Value™: ¥7.92 vs. price of ¥5.59 (29.4% below fair value)
No single metric tells the full story. See the BJSE:920575 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Health Guard Biotechnology Inc engages in the research, development, and industrialization of recombinant protein vaccines. It mainly develops HPV vaccines in China and also advances multiple innovative candidate vaccines for other infectious diseases. Its core pipeline product includes a trivalent and a nonavalent HPV vaccine.
47GF Score
Get the complete analysis for BJSE:920575
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920575 has been successfully added to your 
